August 15, 2024 – Imidazolidin

The original phase I crizotinib trial (PROFILE1001, NCT00585195), the assay for

Chemexpress August 15, 2024 0 Comments

The original phase I crizotinib trial (PROFILE1001, NCT00585195), the assay for the trial to detect ROS1-rearrangement can be a locally created laboratory-based test and no formal CDx is being developed…

Uncategorized

Have been immunoblotted with anti-AMPK , anti-P-AMP , anti-raptor, anti-P-raptor, anti-mTOR, anti-P-mTOR, anti-S6K

Chemexpress August 15, 2024 0 Comments

Have been immunoblotted with anti-AMPK , anti-P-AMP , anti-raptor, anti-P-raptor, anti-mTOR, anti-P-mTOR, anti-S6K, anti-P-S6K, anti-S6, anti-P-S6, anti-4EBP1, anti-P-4EBP1, or anti-HA antibodies. Anti-GAPDH was employed to verify equal protein loading. The…

The original phase I crizotinib trial (PROFILE1001, NCT00585195), the assay for

Have been immunoblotted with anti-AMPK , anti-P-AMP , anti-raptor, anti-P-raptor, anti-mTOR, anti-P-mTOR, anti-S6K

You Missed

(2R)-2-[(ethoxycarbonyl)methyl]-4-methylpentanoic acid (CAS 181289-10-1)

2′-O-Benzyloxy-2-O-desmethylcarvedilol (CAS 72955-92-1)

1-[(3-phenyl-1,2,4-oxadiazol-5-yl)methyl]piperazine dihydrochloride

2′-Deoxyguanosine 5′-triphosphate sodium salt (CAS 18423-40-0)